Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
3.020
-0.147 (-4.64%)
At close: Dec 5, 2025, 4:00 PM EST
3.010
-0.010 (-0.33%)
After-hours: Dec 5, 2025, 6:25 PM EST
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $9.44 million as of December 5, 2025. Its market cap has increased by 408.10% in one year.
Market Cap
9.44M
Enterprise Value
2.22M
1-Year Change
408.10%
Ranking
Category
Stock Price
$3.02
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $9.44M, a decrease of -93.64%. That is a compound annual growth rate of -44.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 9.90M | 207.31% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |